Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HMS Holdings Corp. was a prominent healthcare technology company specializing in cost containment and payment integrity solutions for healthcare payers. The company provided a suite of services including coordination of benefits, payment accuracy, and population health management to government and commercial health plans. By leveraging advanced data analytics and proprietary technology, HMS helped clients reduce costs, improve clinical outcomes, and ensure regulatory compliance. Their primary clients included state Medicaid agencies, the Centers for Medicare & Medicaid Services (CMS), and private insurance carriers. In April 2021, the company was acquired by Gainwell Technologies for approximately $3.4 billion, integrating its capabilities into a broader portfolio of health and human services technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HMS.